对MDPHP急性中毒病例的临床表现和分析报告
Davide Arillotta1, Arianna Totti2, Alexandra Dimitrova3
1Department of Neurosciences, Psychology, Drug Research and Child Health, Section of Pharmacology and Toxicology, University of Florence, Florence, Italy.
Journal of pharmaceutical and biomedical analysis
|January 26, 2024
概括
这项研究详细介绍了17例MDPHP (一种合成卡西) 的摄入情况,揭示了严重的精神,神经和心脏毒性症状. 先进的液体染色学-双重质谱仪对于检测这种强效物质至关重要.
科学领域:
- 法医毒理学 法医毒理学
- 药理学 药理学是指药理学的学科.
- 临床化学 临床化学
背景情况:
- MDPHP是α-pyrrolidinophenone的一个强有力的合成甲基 (SC) 衍生物.
- SCs是中枢神经系统的兴奋剂,有可能产生严重的不良影响.
- 对于MDPHP中毒存在有限的病例报告,需要进一步的临床和分析调查.
研究的目的:
- 在17例MDPHP摄入病例中描述临床表现和分析结果.
- 突出诊断挑战和必要的先进分析技术,用于SC检测.
- 为医疗保健提供者和成专家提供有关MDPHP相关风险的信息.
主要方法:
- 对17例有记录的MDPHP摄入量的病例进行了回顾性分析.
- 在血液和尿液中使用液体染色学-并联质谱法 (LC-MS/MS) 量化MDPHP.
- 临床数据收集,包括症状,并发症和治疗结果.
主要成果:
- 在血液 (1.26-73.30 ng/mL) 和尿液 (19.31-8769.64 ng/mL) 中检测到MDPHP.
- 观察到严重的精神,神经,呼吸系统症状,体溶解和心脏毒性.
- 同时使用其他物质,特别是精神兴奋剂是常见的,使临床评估复杂化.
结论:
- 摄入MDPHP与严重和可能危及生命的健康后果有关.
- 像LC-MS/MS这样的先进分析方法对于准确识别MDPHP和其他新型精神活性物质 (NPS) 是必不可少的.
- 多学科的方法和提高意识对于管理MDPHP中毒至关重要,特别是在弱势群体中.
相关概念视频
Prevention of Further Absorption of Poison
823
In cases of acute poisoning, the primary objective is to prevent further absorption of the toxic substance into the body. Immediate interventions using various decontamination techniques targeting the gastrointestinal (GI) tract can achieve this. Decontamination is crucial to prevent poison from entering the systemic circulation, which involves washing affected areas with water and mild soap and removing contaminated clothing. Once external decontamination is done, attention must be turned to...
823
Acute Pancreatitis II: Clinical Manifestations and Management
125
Acute pancreatitis presents a complex medical emergency characterized by rapid onset inflammation of the pancreas, demanding timely diagnosis and management to prevent complications. The condition primarily manifests through severe upper abdominal pain that often radiates to the back. This pain intensifies following the consumption of fatty foods. Accompanying symptoms such as nausea, vomiting, abdominal distention, fever, dyspnea, cyanosis, and jaundice can vary in intensity but significantly...
125
Toxic Reactions: Overview
975
When toxic substances penetrate the human body, they disseminate to various tissues, undergoing metabolic changes. This process yields reactive metabolites that may covalently bind with specific target molecules, resulting in toxicity.
Toxicity falls into two primary categories: local and systemic.
Local toxicity appears at the exposure site, such as protein denaturation caused by caustic substances.
In contrast, systemic toxicity requires the toxic agent's absorption and distribution,...
Toxicity falls into two primary categories: local and systemic.
Local toxicity appears at the exposure site, such as protein denaturation caused by caustic substances.
In contrast, systemic toxicity requires the toxic agent's absorption and distribution,...
975
Anticholinesterase Agents: Poisoning and Treatment
859
Anticholinesterases, also known as cholinesterase inhibitors, work by blocking the breakdown of acetylcholine, leading to its accumulation in the synaptic cleft. This accumulation indirectly enhances both muscarinic and nicotinic actions. These agents are classified as reversible or irreversible based on their mechanism of action.
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is...
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is...
859
Antidotes
649
Antidotes are medicinal substances used to counteract the harmful effects of toxins or drugs in the body. They function in various ways, each uniquely designed to combat specific toxic compounds.
Specific antidotes operate by inhibiting the enzymes that control biochemical pathways, reducing the production of harmful metabolites.
An example of an antidote is atropine, which counteracts the detrimental effects of cholinesterase inhibitors. It achieves this by deactivating muscarinic receptors,...
Specific antidotes operate by inhibiting the enzymes that control biochemical pathways, reducing the production of harmful metabolites.
An example of an antidote is atropine, which counteracts the detrimental effects of cholinesterase inhibitors. It achieves this by deactivating muscarinic receptors,...
649


